Phenobarbital Antibody (F1#2G7A7): sc-57971

Phenobarbital Antibody (F1#2G7A7) is a mouse monoclonal IgG1 antibody that detects Phenobarbital in non-species reactive samples by enzyme-linked immunosorbent assay (ELISA). Phenobarbital, a widely used barbiturate, serves as a critical anticonvulsant, particularly in the treatment of neonatal seizures, where anti-Phenobarbital antibody (F1#2G7A7) helps monitor drug levels comparable to Phenytoin and carbamazepine. However, Phenobarbital use is tempered by significant side effects, including dizziness, nystagmus, and ataxia, which can impact patient compliance and overall treatment outcomes. Phenobarbital′s importance extends beyond therapeutic effects; Phenobarbital monoclonal antibody (F1#2G7A7) aids in studying liver metabolism through hydroxylation and glucuronidation, processes crucial for drug clearance from the body. Understanding these metabolic pathways is essential, as variations in liver function can lead to altered drug levels and potential toxicity, particularly in vulnerable populations such as neonates. With a molecular weight of 232.235 g/mol and a half-life ranging from 53 to 118 hours, Phenobarbital (F1#2G7A7) antibody serves as an invaluable tool for researchers and clinicians studying the pharmacodynamics and safety profiles of this important anticonvulsant.